SPECIAL REPORT
Progression independent of relapse activity (PIRA)
Use of ofatumumab in patients with low disease activity
Safety in pregnancy
Effect of treatment on biomarkers
Latest News
ACTRIMS FORUM 2026 HIGHLIGHTS – TUESDAY, FEBRUARY 10, 2026
February 10, 2026The following summarizes some of the highlights from the Americas Committee for Treatment and Research in MS (ACTRIMS) Forum, held February 5-7, 2026 in San Diego, California.
ACTRIMS FORUM 2026 HIGHLIGHTS – MONDAY, FEBRUARY 9, 2026
February 9, 2026The following summarizes some of the highlights from the Americas Committee for Treatment and Research in MS (ACTRIMS) Forum, held February 5-7, 2026 in San Diego, California.
ACTRIMS Forum 2026 survey
February 3, 2026Help make the NeuroSens coverage of the ACTRIMS Forum 2026 relevant to you.
Complete the survey below to tell us what topics are of greatest interest to you.